Bivalirudin 42023-0622-10
- Manufacturer
- Endo Usa, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 19, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA211215
Need to source Bivalirudin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bivalirudin | 250 mg/1 |
Drug Class
Anti-coagulant [EPC]Direct Thrombin Inhibitor [EPC]Anti-coagulant [EPC]
Selected Package
42023-0622-10Selected10 VIAL, SINGLE-DOSE in 1 CARTON (42023-622-10) / 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (42023-622-01) / 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE